Blonder Tongue Laboratories Inc.

OTC: BDRL    
Share price (5/16/24): $0.12    
Market cap (5/16/24): $1.741 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 3 pages Blonder Tongue Executive Deferred Compensation Agreement
12/34/56
EX-10.1
from 8-K 3 pages Stock Purchase Agreement
12/34/56
EX-10.2
from 8-K 1 page Promissory Note
12/34/56
EX-10.1
from 8-K 3 pages Stock Purchase Agreement
12/34/56
EX-10.1
from 8-K 2 pages Blonder Tongue Laboratories, Inc. Robert J. Pallé Omnibus Amendment of Non-Qualified Stock Option Agreements
12/34/56
EX-10.2
from 8-K 2 pages This Deferred Compensation Agreement (“Agreement”) Is Made as of This Day of January, 2021 (The “Effective Date”), by and Between Blonder Tongue Laboratories, Inc., a Delaware Corporation (The “Company”), and (The “Executive”)
12/34/56
EX-10.1
from 8-K 2 pages This Deferred Compensation Agreement (“Agreement”) Is Made as of This 30th Day of December, 2020 (The “Effective Date”), by and Between Blonder Tongue Laboratories, Inc., a Delaware Corporation (The “Company”), and Edward R. Grauch (The “Executive”)
12/34/56
EX-10.2
from 8-K 23 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 44 pages Securities Purchase Agreement
12/34/56
EX-10.7
from 10-Q 1 page Amendment No. 3 to Blonder Tongue Laboratories, Inc. 2016 Employee Equity Incentive Plan
12/34/56
EX-10.6
from 10-Q 1 page Amendment No. 2 to Blonder Tongue Laboratories, Inc. 2016 Director Equity Incentive Plan
12/34/56
EX-10.5
from 10-Q 1 page Amendment No. 1 to Blonder Tongue Laboratories, Inc. Third Amended and Restated Director Stock Purchase Plan
12/34/56
EX-10.4
from 10-Q 7 pages Third Amended and Restated Director Stock Purchase Plan
12/34/56
EX-10.2
from 8-K 1 page Amendment No. 1 to Blonder Tongue Laboratories, Inc. Second Amended and Restated Executive Stock Purchase Plan
12/34/56
EX-10.1
from 8-K 6 pages Second Amended and Restated Executive Stock Purchase Plan
12/34/56
EX-10.1
from 8-K 2 pages This Deferred Compensation Agreement (“Agreement”) Is Made as of This Day of , 2020 (The “Effective Date”), by and Between Blonder Tongue Laboratories, Inc., a Delaware Corporation (The “Company”), and (The “Executive”)
12/34/56
EX-10.1
from 8-K 2 pages This Deferred Compensation Agreement (“Agreement”) Is Made as of This 3rd Day of May, 2020 (The “Effective Date”), by and Between Blonder Tongue Laboratories, Inc., a Delaware Corporation (The “Company”), and (The “Executive”)
12/34/56
EX-10.5
from 8-K 9 pages Patent and Trademark Security Agreement
12/34/56
EX-10.4
from 8-K 6 pages Continuing Guaranty April 8, 2020
12/34/56
EX-10.1
from 8-K 3 pages This Deferred Compensation Agreement (“Agreement”) Is Made as of This 29th Day of December, 2019 (The “Effective Date”), by and Between Blonder Tongue Laboratories, Inc., a Delaware Corporation (The “Company”), and Edward R. Grauch (The “Executive”)
12/34/56